DPCG(@DPCG_official) 's Twitter Profileg
DPCG

@DPCG_official

De DPCG is de landelijke multidisciplinaire werkgroep op het gebied van alvleesklierkanker

ID:3040456673

linkhttp://www.dpcg.nl calendar_today16-02-2015 10:01:48

224 Tweets

765 Followers

282 Following

Deltaplan Alvleesklierkanker(@DeltaplanA) 's Twitter Profile Photo

Heb je het al gehoord? Op 13 april gaan we fietsen in de Drunense Duinen in Noord-Brabant. Een kans om een sportieve fietstocht te combineren met steun voor het Deltaplan Alvleesklierkanker. We rijden ANWB-fietsroutes van 50, 80 en 130 km …nt.voordeltaplanalvleesklierkanker.nl

Heb je het al gehoord? Op 13 april gaan we fietsen in de Drunense Duinen in Noord-Brabant. Een kans om een sportieve fietstocht te combineren met steun voor het Deltaplan Alvleesklierkanker. We rijden ANWB-fietsroutes van 50, 80 en 130 km …nt.voordeltaplanalvleesklierkanker.nl
account_circle
Simone Augustinus(@Simone_Aug) 's Twitter Profile Photo

Timing of initiation of chemotherapy in asymptomatic metastatic PDAC?

1⃣ Expert opinion: 67% prefer immediate start of chemo
2⃣ Meta-analysis: limited evidence available - no survival difference, potential QOL benefit delayed start of chemo
3⃣ Protocol: let's wait and see! 🙏

Timing of initiation of chemotherapy in asymptomatic metastatic PDAC? 1⃣ Expert opinion: 67% prefer immediate start of chemo 2⃣ Meta-analysis: limited evidence available - no survival difference, potential QOL benefit delayed start of chemo 3⃣ Protocol: let's wait and see! 🙏
account_circle
Simone Augustinus(@Simone_Aug) 's Twitter Profile Photo

New study by DPCG: TIMEPAN trial ⏰

Asymptomatic metastatic PDAC:
▶️Immediate start chemotherapy
⏸️Start when symptoms occur

Primary outcome: quality adjusted survival 👩🏼‍⚕️

➡️Full protocol: pubmed.ncbi.nlm.nih.gov/37897803/

New study by @DPCG_official: TIMEPAN trial ⏰ Asymptomatic metastatic PDAC: ▶️Immediate start chemotherapy ⏸️Start when symptoms occur Primary outcome: quality adjusted survival 👩🏼‍⚕️ ➡️Full protocol: pubmed.ncbi.nlm.nih.gov/37897803/
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

Study protocol multicenter RCT DPCG: EUS- vs surgical gastro-jejunostomy in patients with malignant gastric outlet obstruction. @FrankVleggaar

➡️Inclusion is on schedule

trialsjournal.biomedcentral.com/articles/10.11…

Study protocol #ENDURO multicenter RCT @DPCG_official: EUS- vs surgical gastro-jejunostomy in patients with malignant gastric outlet obstruction. @FrankVleggaar ➡️Inclusion is on schedule trialsjournal.biomedcentral.com/articles/10.11… #PancreaticCancer #alvleesklierkanker
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

Congrats on a wonderful on SBRT radiotherapy and surgery in localized

Interested? ➡️dare.uva.nl/search?identif… 7 studies, 75 co-authors incl RCT and study.

Thanks to anna bruynzeel DPCG and

Congrats #DeesjeDoppenberg on a wonderful #PhD on SBRT radiotherapy and surgery in localized #PancreaticCancer Interested? #Thesis ➡️dare.uva.nl/search?identif… 7 studies, 75 co-authors incl #PANCOSAR RCT and #ULTRAPANC study. Thanks to @AnnA25_03 @DPCG_official and #TAPS
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

Should only be offered in pts with high CA19.9?

Probably not! Joint analysis 🇳🇱 and 🇰🇷 multicenter trials:

✅ 127pts low CA19-9 <500: mOS 23.5 vs 16.3 mo (HR 0.63, 0.42 to 0.93)

❌ 52pts high CA19-9 >500: mOS 15.5 vs

Should #neoadjuvant #chemorad only be offered in #PancreaticCancer pts with high CA19.9? Probably not! Joint analysis #PREOPANC 🇳🇱 and #Jang 🇰🇷 multicenter trials: ✅ 127pts low CA19-9 <500: mOS 23.5 vs 16.3 mo (HR 0.63, 0.42 to 0.93) ❌ 52pts high CA19-9 >500: mOS 15.5 vs
account_circle
PHAIR Consortium(@PHAIRconsortium) 's Twitter Profile Photo

EPC-Europ Pancr Club

Boris Janssen on behalf of PHAIR Consortium!

AI residual cancer burden (RCB) to evaluate impact of NAT in resected pancreatic cancer!

RCB 🔬
NAT vs. upfront: 2.2 vs. 10.3 mm2
p<0.0001

Survival 📈
Above vs. below median RCB: 24 vs. 30 months.
p=0.018

@EurPancClub #EPC2023 @BorisJanssen on behalf of @PHAIRconsortium! AI residual cancer burden (RCB) to evaluate impact of NAT in resected pancreatic cancer! RCB 🔬 NAT vs. upfront: 2.2 vs. 10.3 mm2 p<0.0001 Survival 📈 Above vs. below median RCB: 24 vs. 30 months. p=0.018
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

Amazing 30+ year old tradition celebrating : yesterday, 🇳🇱( ) day between all 7 training regions for 700+ , , incl 2 Amsterdam UMC region teams playing ⚽️🏑🏐🤽‍♂️🎾♣️ and more incl a live

Amazing 30+ year old tradition celebrating #Surgical #TeamSpirit: yesterday, #Chirurgencup 🇳🇱(#SurgeonsCup) day between all 7 training regions for #GeneralSurgery 700+ #surgeons, #residents, #PhDstudents incl 2 @amsterdamumc region teams playing ⚽️🏑🏐🤽‍♂️🎾♣️ and more incl a live
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

What are the learning curves for 🤖
in trained “2nd generation” centers?

635 RPDs performed by teams of 17 surgeons in 7 🇳🇱 DPCG centers. All trained in LAELAPS-3 by Melissa Hogg Herbert Zeh Amer Zureikat

Conversion rate 6.6%,

What are the learning curves for 🤖 #Robotic #Pancreatoduodenectomy in trained “2nd generation” centers? 635 RPDs performed by teams of 17 surgeons in 7 🇳🇱 @DPCG_official centers. All trained in LAELAPS-3 by @HoggNDMD @herbert_zeh @AmerZureikatMD Conversion rate 6.6%,
account_circle
Simone Augustinus(@Simone_Aug) 's Twitter Profile Photo

🚴🏻‍♀️ Help support the CycLyon: ride for pancreatic research team!

🇫🇷 Cycling 650 km from Brescia to E-AHPBA Lyon

🎶 Please add a song to the support playlist:
open.spotify.com/playlist/22WnT…

🚴🏻‍♀️ Help support the @CycLyon2023 team! 🇫🇷 Cycling 650 km from Brescia to @EAHPBA Lyon 🎶 Please add a song to the support playlist: open.spotify.com/playlist/22WnT…
account_circle
PHAIR Consortium(@PHAIRconsortium) 's Twitter Profile Photo

📢 Exciting news! The PHAIR Consortium is officially launching today! 🎉

Launch + excellent presentations by: Lois Daamen, Giuseppe Malleo, Åsmund A. Fretland, Ammar Asrar Javed, MD 🇺🇸, and Jackie Bereska.

PHAIR aims to drive AI advancements for patients with pancreaticobiliary and hepatic diseases.

📢 Exciting news! The @PHAIRconsortium is officially launching today! 🎉 Launch + excellent presentations by: @LoisDaamen, @gimalleo, @AAFretland, @ammar_asrar, and Jackie Bereska. PHAIR aims to drive AI advancements for patients with pancreaticobiliary and hepatic diseases.
account_circle
CycLyon: ride for pancreatic research(@CycLyon2023) 's Twitter Profile Photo

CycLyon 2023: from June 1st to June 6th, a dedicated team of medical researchers will cycle from Brescia to Lyon, to raise funds for pancreatic cancer research. We invite you to follow our journey and support us on Instagram, Facebook, Twitter, and LinkedIn! 🚴‍♂️

CycLyon 2023: from June 1st to June 6th, a dedicated team of medical researchers will cycle from Brescia to Lyon, to raise funds for pancreatic cancer research. We invite you to follow our journey and support us on Instagram, Facebook, Twitter, and LinkedIn! 🚴‍♂️
account_circle
BJS Open(@BjsOpen) 's Twitter Profile Photo

📜by the 🇳🇱 Panc Study group: Network treatment (centralized surgery in expert🏥, adjuvant chemo in local🏥) after panc🔪did not influence time to/completition chemo nor survival! doi.org/10.1093/bjsope… DPCG DutchPancreatitisSG The Pancreas Club

📜by the 🇳🇱 Panc Study group: Network treatment (centralized surgery in expert🏥, adjuvant chemo in local🏥) after panc🔪did not influence time to/completition chemo nor survival! doi.org/10.1093/bjsope… @DPCG_official @pancreatitis_nl @PancreasClub #some4hpb #SoMe4Surgery
account_circle
Marc Besselink(@MarcBesselink) 's Twitter Profile Photo

Harmonizing the USA 🇺🇸 and European🇪🇺 composite markers of into one 🌎 global “ ”: allows comparison of surgical outcomes

Simone Augustinus presenting a project combining data from the registries from: 🇺🇸 🇳🇱 🇩🇪 🇸🇪
europeansurgicalassociation.org/congress

Harmonizing the USA 🇺🇸 and European🇪🇺 composite markers of #Pancreas #Surgery into one 🌎 global “#Ideal #Outcome”: allows comparison of surgical outcomes @Simone_Aug presenting a #GAPASURG project combining data from the registries from: 🇺🇸 🇳🇱 🇩🇪 🇸🇪 europeansurgicalassociation.org/congress
account_circle
Simone Augustinus(@Simone_Aug) 's Twitter Profile Photo

Last call ‼️ Closing 1st May 😱

Are differences in ASA score in HPB surgery actually related to patient factors?

Complete MILESTONE-2 survey: uva.fra1.qualtrics.com/jfe/form/SV_1y…

Already > 1200 responses, from over 53 countries! 🌍

Last call ‼️ Closing 1st May 😱 Are differences in ASA score in HPB surgery actually related to patient factors? Complete MILESTONE-2 survey: uva.fra1.qualtrics.com/jfe/form/SV_1y… Already > 1200 responses, from over 53 countries! 🌍
account_circle
DPCG(@DPCG_official) 's Twitter Profile Photo

Another great quarterly DPCG meeting 🚀

⭐️ Approved 12 retrospective study proposals
🙏 Discussed 3 new prospective studies
🏅 Results of PandigiPET study
🌏 Many new international collaborations
‼️ Audited a quality indicator

Another great quarterly DPCG meeting 🚀 ⭐️ Approved 12 retrospective study proposals 🙏 Discussed 3 new prospective studies 🏅 Results of PandigiPET study 🌏 Many new international collaborations ‼️ Audited a quality indicator
account_circle